Skip to main content

Advertisement

SpringerLink
Log in

Nutrition and renal cell cancer

  • Review Papers
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Epidemiologic evidence on the relation between nutrition and renal cell cancer is reviewed. Kidney cancer, comprising 1.7 percent of all malignant diseases diagnosed worldwide, shows about a 20-fold international variation in the incidence in men and 10-fold in women. This substantial variation indicates an important causal role of environmental factors. Renal cell (parenchymal) cancer (RCC) accounts for about 80 percent of all kidney cancers. While the etiology of RCC is incompletely understood, analytic epidemiologic studies provide consistent support for a positive association of obesity with risk of RCC; the dose-response observed supports a causal relationship. Only a few prospective studies, all of them limited in size, have been published, while ecologic and case-control studies suggest that diet may be important in the etiology of RCC. However, contradictory results and methodologic limitations in some casecontrol studies prevent definite conclusions concerning diet and RCC. A positive association of protein and fat intake, as well as their main food sources (meat, milk, fats), with risk of RCC-as suggested by ecologic studies—has no clear support in analytic epidemiologic studies. A protective effect of vegetables and fruits has been observed in most casecontrol studies, while the majority do not show an association between alcohol, coffee, and risk of RCC. Recent reports indicated an increased risk of RCC associated with consumption of fried/sautéed meat and low intakes of magnesium or vitamin E. An apparent positive association with total energy intake, perhaps due to bias, needs further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606.

    Google Scholar 

  2. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993; 5: 891–903.

    Google Scholar 

  3. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JFJr. Recent cancer trends in the United States. JNCI 1995; 87: 175–82.

    Google Scholar 

  4. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS 1995; Suppl 49: 90–5.

  5. Franceschi S, Levi F, La Vecchia C, Lucchini F, Negri E. Comparison of cancer mortality trends in major European areas, 1960–89. Eur J Cancer Prev 1994; 3: 145–206.

    Google Scholar 

  6. The Cancer Registry. Cancer Incidence in Sweden 1992. Stockholm, Sweden: National Board of Health and Welfare, 1995.

    Google Scholar 

  7. Whelan SL, Parkin DM, Masuyer E. Patterns of Cancer in Five Continents. Lyon, France: International Agency for Research on Cancer, 1990; IARC Sci. Pub. No. 102.

    Google Scholar 

  8. McCredie M, Pommer W, McLaughlin JK, et al. International renal cell cancer study. II. Analgesics. Int J Cancer 1995; 60: 345–9.

    Google Scholar 

  9. Mandel JS, McLaughlin JK, Schlehofer B et al. International renal cell cancer study. IV. Occupation. Int J Cancer 1995; 61: 601–5.

    Google Scholar 

  10. Lindblad P, Mellemgaard A, Schlehofer B, et al. International renal cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 1995; 61:192–8.

    Google Scholar 

  11. McLaughlin J, Chow WH, Mandel J, et al. International renal cell cancer study. VIII. Role of diuretics, other antihypertensive medications and hypertension. Int J Cancer, in press.

  12. Mellemgaard A, Bergstrom R, Lindblad P, et al. International renal cell cancer study: III. Role of weight, height, physical activity and use of amphetamines. Int J Cancer 1995; 60: 350–4.

    Google Scholar 

  13. Wolk A, Gridley G, Niwa S, et al. International renal cell cancer study: VII. Role of diet. Int J Cancer 1995; 65: 67–74.

    Google Scholar 

  14. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617–31.

    Google Scholar 

  15. Wynder EL, Mabuchi K, WhitmoreJr WF. Epidemiology of adenocarcinoma of the kidney. JNCI 1974; 53: 1619–34.

    Google Scholar 

  16. Shennan DH. Renal carcinoma and coffee consumption in 16 countries (Letter). Br J Cancer 1973; 28: 473–4.

    Google Scholar 

  17. Breslow NE, Enstrom JE. Geographic correlations between cancer mortality rates and alcohol-tobacco consumption in the United States. JNCI 1974; 53: 631–9.

    Google Scholar 

  18. Hinds MW, Kolonel LN, Lee J, Hirohata T. Associations between cancer incidence and alcohol/cigarette consumption among five ethnic groups in Hawaii. Br J Cancer 1980; 41: 929–40.

    Google Scholar 

  19. McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JFJr. A population-based case-control study of renal cell carcinoma. JNCI 1984; 72: 275–84.

    Google Scholar 

  20. Maclure M, Willett W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1990; 1: 430–40.

    Google Scholar 

  21. Chow WH, Gridley G, McLaughlin JK, et al. Protein intake and risk of renal cell cancer. JNCI 1994; 86: 1131–9.

    Google Scholar 

  22. Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history. Cancer Causes Control 1994; 5: 105–13.

    Google Scholar 

  23. Lindblad P, Wolk A, Bergstrom R, Adami HO. Diet and risk of renal cell cancer: A population-based case-control study in Sweden. (Submitted)

  24. Mellemgaard A, McLaughlin J, Overvad K, Olsen JH. Dietary risk factors of renal cell carcinoma in Denmark. (Submitted)

  25. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986; 124: 17–27.

    Google Scholar 

  26. Howe GR, Miller AM, Jain M. Re: “Total energy intake: implications for epidemiologic analyses”. Am J Epidemiol 1986; 124: 157–9.

    Google Scholar 

  27. Pike MC, Bernstein L, Peters RK. Re: “Total energy intake: implications for epidemiologic analyses”. Am J Epidemiol 1989; 129: 1312–3.

    Google Scholar 

  28. Palmgren J, Kushi LH. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1991; 133: 1291–3.

    Google Scholar 

  29. Kipnis V, Freedman LS, Brown CC, et al. Interpretation of energy adjustment models for nutritional epidemiology. Am J Epidemiol 1993; 137: 1376–80.

    Google Scholar 

  30. Brown CC, Kipnis V, Freedman LS, et al. Energy adjustment methods for nutritional epidemiology: The effect of categorization. Am J Epidemiol 1994; 139: 323–38.

    Google Scholar 

  31. Wacholder S, Schatzkin A, Freedman LS, et al. Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol 1994; 140: 848–55.

    Google Scholar 

  32. Das S. Vitamin E in the genesis and prevention of cancer. Acta Oncol 1994; 6: 615–9.

    Google Scholar 

  33. Elin RJ, Magnesium metabolism in health and disease. Dis Mon 1988; 34: 161–218.

    Google Scholar 

  34. Blondell JM. The anticarcinogenic effect of magnesium. Med Hypotheses 1980; 6: 863–71.

    Google Scholar 

  35. Armstrong B, Garrod A, Doll R. A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer 1976; 33: 127–36.

    Google Scholar 

  36. Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. JNCI 1986; 77: 351–6.

    Google Scholar 

  37. McCredie M, Ford JM, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer 1988; 42: 13–6

    Google Scholar 

  38. Talamini R, Baron AE, Barra S, et al. A case-control study of risk factor for renal cell cancer in northern Italy. Cancer Causes Control 1990 1: 125–31.

    Google Scholar 

  39. Negri E, La Vecchia C, Franceschi S, D'Avanzo B, Parazzini F. Vegetable and fruit consumption and cancer risk. Int J Cancer 1991; 48: 350–4.

    Google Scholar 

  40. McLaughlin JK, Gao YT, Gao RN, et al. Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer 1992; 52: 562–5.

    Google Scholar 

  41. Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993; 4: 101–10.

    Google Scholar 

  42. Fraser GE, Philips RL, Beeson WL, Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-day Adventisis. Int J Epidemiol 1990; 19: 832–8.

    Google Scholar 

  43. Munro IC, Kennepohl E, Erickson RE, et al. Safety assessment of ingested heterocyclic amines: initial report. Regul Toxicol Pharmacol 1993; 17: s1-s109.

    Google Scholar 

  44. Outzen HC, MaguireJr HC. The etiology of renal-cell carcinoma. Semin Oncol 1983; 10: 378–84.

    Google Scholar 

  45. Strube M, Dragsted LO, Larsen JC. Naturally Occurring Antitumorigens—I. Plant Phenols. Copenhagen, Denmark: The Nordic Council of Ministers, 1993; Nordic Conference-and Progress Reports: 605.

    Google Scholar 

  46. Strube M, Dragsted LO, Larsen JC. Naturally Occurring Antitumorigens—II. Organic Isothiocyanates. Copenhagen, Denmark: The Nordic Council of Ministers, 1994; Nordic Conference-and Progress Report: 539.

    Google Scholar 

  47. Dorant E, van den Brandt PA, Goldbohm RA, et al. Garlic and its significance for the prevention of cancer in humans: a critical view. Br J Cancer 1993; 67: 424–9.

    Google Scholar 

  48. Abdullah TH, Kandil O, Elkadi A, Carter J. Garlic revisited: therapeutic for the major diseases of our times? J Natl Med Assoc 1988 80(4): 439–45.

    Google Scholar 

  49. Asal NR, Risser DR, Kadamani S, Geyer JR, Lee ET, Cherng N. Risk factors in renal cell carcinoma: I. Methodology, demographics, tobacco, beverage use, and obesity. Cancer Detect Prev 1988; 11: 359–77.

    Google Scholar 

  50. Harrington JM, Whitby H, Gray CN, Reid FJ, Aw TC, Waterhouse JA. Renal disease and occupational exposure to organic solvents: a case-referent approach: see comments. Br J Ind Med 1989; 46: 643–50.

    Google Scholar 

  51. Partanen T, Heikkila P, Hernberg S, Kauppinen T, Moneta G, Ojajarvi A. Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ Health 1991; 17: 231–9.

    Google Scholar 

  52. Goodman MT, Morgenstern H, Wynder EL. A case-control study of factors affecting the development of renal cell cancer. Am J Epidemiol 1986; 124: 926–41.

    Google Scholar 

  53. Benhamou S, Lenfant MH, Ory-Paoletti C, Flamant R. Risk factors for renal-cell carcinoma in a French casecontrol study. Int J Cancer 1993; 55: 32–6.

    Google Scholar 

  54. Hiatt RA, Tolan K, QuesenberryJr CP. Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA). Cancer Causes Control 1994; 5: 319–25.

    Google Scholar 

  55. Brownson RC. A case-control study of renal cell carcinoma in relation to occupation, smoking, and alcohol consumption. Arch Environ Health 1988; 43: 238–41.

    Google Scholar 

  56. Asal NR, Geyer JR, Risser DR, Lee ET, Kadamani S, Cherng N. Risk factors in renal cell carcinoma. II Medical history, occupation, multivariate analysis and conclusions. Cancer Detect Prev 1988; 13: 263–79.

    Google Scholar 

  57. Kadamani S, Asal NR, Nelson RY. Occupational hydrocarbon exposure and risk of renal cell carcinoma. Am J Ind Med 1989; 15: 131–41.

    Google Scholar 

  58. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 1992; 3: 323–31.

    Google Scholar 

  59. Finkle WD, McLaughlin JK, Rasgon SA, Yeoh HH, Low JE. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control 1993; 4: 555–8.

    Google Scholar 

  60. Lindblad P, Wolk A, Bergstrom R, Persson I, Adami HO. The role of obesity and weight fluctuations in the aetiology of renal cell cancer. A population-based case-control study. Cancer Epidemiol Biomark Prev 1994; 3: 631–9.

    Google Scholar 

  61. Ronchi E, Pizzocaro G, Miodini P, Piva L, Salvioni R, Di Fronzo G. Steroid hormone receptors in normal malignant human renal tissue: relationship with progestin therapy. J Steroid Biochem 1984; 21: 329–34.

    Google Scholar 

  62. Reznik-Schuller H. Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters. JNCI 1979; 62: 1083–8.

    Google Scholar 

  63. Li JJ, Li SA. Estrogen carcinogenesis in hamster tissues: a critical review. Endocr Rev 1990; 11: 524–31.

    Google Scholar 

  64. Barrett JC, Huff J. Cellular and molecular mechanisms of chemically induced renal carcinogenesis. Renal Failure 1991; 13: 211–25.

    Google Scholar 

  65. Traish AM, Wotiz HH. Prostatic epidermal growth factors and their regulation by androgen. Endrocrinology 1987; 121: 1461–7.

    Google Scholar 

  66. Concolino G, Lubrano C, Santonati A, Di Silverio F, Catizone A, Conti C. Epidermal growth factor (EGF) binding by normal and neoplastic human renal tissue. J Tumor Marker Oncol 1989; 4: 89–97.

    Google Scholar 

  67. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993; 14: 72–93.

    Google Scholar 

  68. Wald N, Idle M, Boreham J, Bailey A. Low serum-vitamin-A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet 1980; 2: 813–5.

    Google Scholar 

  69. Kark JD, Smith AH, Switzer BR, Hames CG. Serum vitamin A (retinol) and cancer incidence in Evans county, Georgia. JNCI 1966; 76: 7–16.

    Google Scholar 

  70. Jacobsen BK, Bjelke E, Kvåle G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. JNCI 1986 76: 823–31.

    Google Scholar 

  71. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994; 5: 401–8.

    Google Scholar 

  72. Kinlen LJ, Wollows AN, Goldblatt P, Yudkin J. Tea consumption and cancer. Br J Cancer 1988; 58: 397–401.

    Google Scholar 

  73. Wilkins JR, Comstock GW. Source of drinking water at home and site-specific cancer incidence in Washington county, Maryland. Am J Epidemiol 1981; 114: 178–90.

    Google Scholar 

  74. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992; 66: 888–92.

    Google Scholar 

  75. Smith AH, Hopenhayn-Rich C, Bates MM, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992; 97: 259–67.

    Google Scholar 

  76. Adami HO, McLaughlin JK, Hsing AW, et al. Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control 1992; 3: 419–25.

    Google Scholar 

  77. Schmidt W, De Lint J. Causes of death of alcoholics. Q J Stud Alcohol 1972; 33: 171–85.

    Google Scholar 

  78. Pell S, D'Alonzo CA. A five-year mortality study of alcoholics. J Occup Med 1973; 15(2): 120–5.

    Google Scholar 

  79. Monson RR, Lyon JL. Proportional mortality among alcoholics. Cancer 1975; 36: 1077–9.

    Google Scholar 

  80. Jensen OM. Cancer morbidity and causes of death among Danish brewery workers. Int J Cancer 1979; 23: 454–63.

    Google Scholar 

  81. Whittemore AS, PaffenbargerJr RS, Anderson K, Lee JE. Early precursors of urogenital cancers in former college men. J Urol 1984; 132: 1256–61.

    Google Scholar 

  82. Whittemore AS, PaffenbargerJr RS, Anderson K, Lee JE. Early precursors of site-specific cancers in college men and women. JNCI 1985; 74: 43–51.

    Google Scholar 

  83. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979; 32: 563–76.

    Google Scholar 

  84. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1993; 30A: 344–50.

    Google Scholar 

  85. Clinton SK, Imrey PB, Mangian HJ, Nandkumar S, Visek WJ. The combined effects of dietary fat, protein, and energy intake on azoxymethane-induced intestinal and renal carcinogenesis. Cancer Res 1992; 52: 857–65.

    Google Scholar 

  86. McLean AE, Magee PN. Increased renal carcinogenesis by dimethyinitrosamine in protein deficient rats. Br J Exp Pathol 1970; 51: 587–90.

    Google Scholar 

  87. Swan PR, McLean AE. Cellular injury and carcinogesis: the effect of a protein-free high-carbohydrate diet on the metabolism of dimethylnitrosamine in the rat. Biochem 1971; 124: 283–8.

    Google Scholar 

  88. Campbell TC, Hayes JR. The effect of quantity and quality of dietary protein on drug metabolism. Fed Proc 1976; 35: 2470–4.

    Google Scholar 

  89. Clinton SK, Truex CR, Visek WJ. Dietary protein, aryl hydrocarbon hydrozylase and chemical carcinogenesis in rats. J Nutr 1979; 109: 55–62.

    Google Scholar 

  90. Liehr JG, Sirbasku DA. Estrogen-dependent kidney tumors. In: Taub M, ed. Tissue Culture of Epitbelial Cells. New York, NY(USA). Plenum Publishing 1985; 205–234.

    Google Scholar 

  91. Liehr JG. Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethyistilbestrol. Am J Clin Nurt 1991; 54: 1256S-60S.

    Google Scholar 

  92. Hirose M, Yada H, Hakoi K, Takahashi S, Ito N. Modification of carcinogenesis by alpha-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model. Carcinogenesis 1993; 14: 2359–64.

    Google Scholar 

  93. Cholbi MR, Paya M, Alcaraz MJ. Inhibitory effects of phenolic compounds on CCl4-induced microsomal lipid peroxidation. Experimentia 1991; 47: 195–9.

    Google Scholar 

  94. Zhu BT, Liehr JG. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol Appl Pharmacol 1994; 125: 149–58.

    Google Scholar 

  95. Bogden JD, Gertner SB, Kemp FW, McLeod R, Bruening KS, Chung HR. Dietary lead and calcium: effects on blood pressure and renal neoplasia in Wistar rats. J Nutr 1991; 121: 718–28.

    Google Scholar 

  96. Kurokawa Y, Maekawa A, Takahashi M, Hayashi Y. Toxicity and carcinogenicity of potassium bromate—a new renal carcinogen. Environ Health Perspect 1990; 87: 309–35.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Epidemiology, University Hospital, Uppsala, Sweden

    Alicja Wolk, Per Lindblad & Hans-Olov Adami

  2. Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA

    Hans-Olov Adami

Authors
  1. Alicja Wolk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Per Lindblad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans-Olov Adami
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This project was funded partially by the Swedish Cancer Society.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolk, A., Lindblad, P. & Adami, HO. Nutrition and renal cell cancer. Cancer Causes Control 7, 5–18 (1996). https://doi.org/10.1007/BF00115634

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00115634

Key words

Search

Navigation